Aggregator
50 Iranian Tanker Logjam Unfolds As US Naval Blockade Starves Tehran Of Oil Revenue
Bloomberg cites a new report from United Against Nuclear Iran that claims the US naval blockade of the Strait of Hormuz has created a parking lot of more than 50 Iranian tankers that dare not cross the critical waterway.
The nonprofit think tank, which focuses on combating threats posed by Iran, said the number of laden tankers was broadly unchanged from two months earlier. The tankers were mostly carrying crude, along with some petroleum products and LNG.
UANI also noted that empty tankers were waiting at anchorages across the Indo-Pacific region rather than returning to Iranian ports, adding that at least 20 Iran-flagged ships were positioned off Sri Lanka and another was off Oman.
UANI's report comes days after Bloomberg said Iran's crude loadings fell to zero in September.
Over the weekend, Treasury Secretary Scott Bessent joined Mike Allen on "The Axios Show" and confirmed: "For the first time in history, they [Iran], since they started pumping oil, they will have no oil on the water this week. They will have no revenue."
Bessent on Iran: For the first time in history, since they started pumping oil, they will have no oil on the water this week. They will have no revenues. https://t.co/PIrHwUCG4q
— Clash Report (@clashreport) October 3, 2026Separately, last week, Goldman analysts Yulia Zhestkova Grigsby, Alexandra Paulus, and Daan Struyven told clients that a "divergence between the fall of Iranian exports and the rise of exports of other Persian Gulf producers" was underway.
The Goldman energy experts estimated that "dark exports" have helped boost Persian Gulf oil exports to 23.3 million barrels a day late last month, back to prewar levels.
All indications so far point to the Trump administration's "Operation Economic Outcast" working as planned, with allied Gulf exports continuing to flow while Iran is starved of oil revenue amid the blockade. The question is whether this plan should've been implemented on day one of the conflict.
Tyler Durden Tue, 10/06/2026 - 11:20Wild Andrew Tate claims include ‘extreme porn,’ bestiality pics with horse and eel as disturbing full allegations revealed
Dodgers World Series architect Fred Claire dies on 91st birthday
Metallica Sphere concert reviews are in. Here’s what critics are saying
AOC privately gushes if El-Sayed pulls off victory in Michigan, lefties will win ‘anywhere’
Anthropic CEO Dario Amodei made $18M last year: IPO filing
Suspected pneumonic plague outbreak erupts in Russia after scientist dies
Lakers’ Luka Doncic returns to ‘one of the best things in my life’ in epic fashion
AI Geniuses Are Decidedly Not Policy And Economic Geniuses
Authored by David McGarry via RealClearMarkets,
Geniuses are an odd species. To paraphrase Montesquieu, the exceptional are often also a bit loony. Cornelius Vanderbilt, a devotee of spiritualism, believed himself to have communicated with the spirit of George Washington. To improve his health, Henry Ford devoured weeds, and Thomas Alva Edison was averse to bathing. The point: geniuses are an odd species, who, for all the indispensability of their works to American prosperity and innovation, ought not be trusted credulously. Today in Washington, D.C., Congress must endeavor to protect artificial intelligence (AI) from the technologists most prominent in its creation.
Anthropic's Dario Amodei desires the U.S. government (an agent of compulsion) to dictate the "pace" of innovation, as the CEO wrote this month. "I have become convinced that fully addressing the risks requires even more prudence - not just investing in risk prevention, but pacing the rate of capabilities advancement so that risk prevention has time to keep up." Amodei warns of impending catastrophe should innovation continue at its current rate. Yet his company, the creator of what he supposes to be a tool of catastrophic potential, demands state-imposed fetters. Anthropic will institute some precautions, but not thoroughgoing "safety standards as well as limits on the rate of unchecked AI progress" - not until such standards and limits bind the entire industry. This means, in simpler terms, the kind of regulatory scheme Anthropic prefers - the kind that jars with the principles of antitrust law and would, as David Sacks notes, shelter the company's market share from the gales of competition.
The "prudence" of Amodei and the other pessimists is more rascally than genuine; it is an age-old propensity to see evil lurking in every major innovation and demand statism to manage it. The experience of the ages did not vindicate such assumptions when the printing press brought on a flood of "confusing and harmful" literature, when the typewriter displaced the human hand, or when the emergence of machines caused economist John Maynard Keynes, in the 1930s, to declare: "We are being afflicted with a new disease, technological unemployment."
In 2016, Geoffrey Hinton, the "Godfather of AI," predicted the demise of human radiologists, which field is, a decade on, employing human beings at record rates. Explaining his error, Hinton recently confessed that, a decade ago, he was ignorant of important facts. Unreformed, Hinton recently likened an episode in which an OpenAI agent, improperly set free from technical constraints, hacked Hugging Face to the nuclear reactor explosion at Chernobyl. He allowed Congress about a year to fend off disaster by regulating the technology.
The regulatory model favored by the pessimists is likely to subject free innovation to cartelization, free speech to state control, and the American system of property rights and free exchange to the will of bureaucratic juntas. As the Taxpayers Protection Alliance argued, even those pessimists who "consider themselves conservatives on technological questions...propose to embark upon a revolution in American government. To preserve the good life, they tell us, we must jettison the freedoms on which the pursuit of happiness depends. No vain denials of the scope of proposed state control can convincingly gainsay that contradiction."
The marriage of pessimism and statism has arrived on Capitol Hill, where many are in a mood to regulate AI - and to do so aggressively. Myriad bills have been introduced, and - among others, presumably - Senate Majority Leader John Thune (R-S.D.) and Sen. Amy Klobuchar (D-Minn.) are concocting what is likely to be a prominent addition to the collection. House Minority Leader Hakeem Jeffries (D-N.Y.) recently articulated the fearful position well, advocating "decisive congressional action immediately, in a manner consistent with what some of the leading AI voices in the country are now saying needs to happen."
All the while, President Donald Trump and many in Congress - including Speaker Mike Johnson (R-La.) - have resisted the paranoiacs. They remain confident in the American system: free innovation within the confines of traditional legal principles developed throughout the course of centuries to protect the rights of citizens from corporate excesses.
Doubtless, the captains of industry now building frontier AI models can accomplish innovative feats beyond the ken and capacities of all but a few Americans, let alone the median Washington, D.C., politician or bureaucrat. But their knowledge of politics and economics - of the ends of government and the means necessary to secure them - is not to be assumed. It is the office of the technologist to understand how to innovate, and that of the congressman to understand how to govern. The fretting and the myopias of the one should not rule the judgment of the other. A federal regulatory standard, enacted by Congress, is a sine qua non of sustained American innovation. But it must be built upon a foundation of practicality and not fanciful timidity, experience and not theory, and sound principles - the principles native to this land of liberty - and not statist reaction.
We publish a variety of perspectives. Nothing written here is to be construed as representing the views of ZeroHedge.
Tyler Durden Tue, 10/06/2026 - 11:00How Burger King tries to make customers feel important — without feeling inauthentic
Illegal alien wanted by ICE identified as suspect in off-duty NYPD cop slashing attack
Former news anchor learns fate for stabbing her mother to death believing she was ‘the devil’
Taylor Swift ends Ella Langley’s record-breaking Hot 100 streak
Taylor Swift ends Ella Langley’s record-breaking Hot 100 streak
Federal Survey Of 21,990 Kids Ties COVID Shots To Autism, ADHD
Authored by Steve Watson via Modernity.news,
A new analysis of the federal National Health Interview Survey finds children who received a COVID-19 shot had higher odds of autism, ADHD, anxiety, asthma and special-education use than children who did not.
The authors, including epidemiologist Nicolas Hulscher and cardiologist Peter McCullough, say the pattern survived a long list of statistical controls and rose with dose count.
Their conclusion is blunt: COVID-19 vaccination of children should cease immediately.
Neurodevelopmental Outcomes in COVID-19-Vaccinated Versus Unvaccinated U.S. Children: Analysis of the National Health Interview Survey, 2022-2024: https://t.co/slUVkwGFqf@McCulloughFund @P_McCulloughMD @NathanMeadPhD @Docjohnc
— Nicolas Hulscher, MPH (@NicHulscher) October 5, 2026The paper, posted October 5 on the Zenodo repository, pools the 2022-2024 Sample Child files. It covers 21,990 children aged 0-17 with a recorded COVID vaccination status, and 19,882 aged 2-17 for the autism, ADHD and learning-disability items.
"Unvaccinated" in this comparison means no COVID-19 vaccine. It does not mean the child skipped the routine schedule.
Set against children who never received a COVID shot, COVID-vaccinated children had:
- 32 percent higher odds of current autism
- 26 percent higher odds of a lifetime autism diagnosis
- 33 percent higher odds of ADHD
- 23 percent higher odds of any neurodevelopmental diagnosis
- 19 percent higher odds of special-education use
- 24 percent higher odds of asthma
- 27 percent higher odds of daily or weekly anxiety
- 57 percent higher odds of mental-health medication
- 60 percent higher odds of mental-health therapy
The steepest autism estimate landed where parents were told the product was a routine precaution. Among children aged 5 to 7, three or more COVID shots were linked to 154 percent higher odds of current autism. Ages 2 to 7 with three or more doses sat at 137 percent higher odds.
The odds also climbed with the number of shots. Against children who received none, current-autism odds were 3 percent higher after one dose, 25 percent higher after two, and 40 percent higher after three or more.
Hulscher told The Gateway Pundit the association "persisted across numerous adjustment strategies, strengthened with increasing dose count, and reached its largest estimate in some of the youngest multiply vaccinated children."
He added: "This is a safety signal that must not be ignored. Endangering the developing brain is a red line. COVID-19 'vaccination' of children should cease immediately."
BREAKING STUDY: "COVID-19 'Vaccination' of Children Should Cease Immediately" https://t.co/PjpwHpxjnB
— The Gateway Pundit (@gatewaypundit) October 5, 2026The authors say the autism signal held after accounting for age, sex, race, income, parental education, insurance, region, healthcare access, wellness visits, emergency-room use, hospitalization, prescription use and influenza vaccination.
It remained after a balancing method that wiped out measured differences between the groups, and after the analysis was limited to children without asthma, diabetes or fair or poor health.
Influenza and HPV shots were run as comparison exposures. Children who received a COVID shot but not a flu shot had 45 percent higher autism odds than children who received a flu shot but not a COVID shot.
They also state the limit their design cannot escape. The survey is cross-sectional. It cannot put the shot before the diagnosis in calendar time, and it cannot test the full routine childhood schedule.
A linked birth-cohort study is what they say should come next. That is a real constraint. It is not a reason the CDC, FDA or the manufacturers spent four years refusing to run the comparison on their own books.
CDC surveillance now puts autism at 1 in 31 American 8-year-olds. For boys the figure is 1 in 20, and in California, which has the tighter data, about 1 in 12.5 boys. Two years before those numbers landed, the national rate was 1 in 36.
Health Secretary Robert F. Kennedy Jr. put the denial in plain language in April 2025. "It's clear that the rates are real. Year by year there is a steady, relentless increase," he said. "This is a preventable disease. We know it's an environmental exposure. It has to be. Genes do not cause epidemics."
He described children who "were fully functional and regressed because of some environmental exposure into autism when they're two years old."
By September 2025 the department had stopped treating the question as forbidden. NIH's Autism Data Science Initiative set aside more than $50 million for 13 projects on environmental, medical and perinatal influences, and named medications and vaccinations as exposures under study.
Kennedy said the department was "closely examining" vaccines, and noted that "some 40 to 70% of mothers who have children with autism believe that their child was injured by a vaccine." President Trump's line at the same moment was shorter: "They pump so much stuff into those beautiful little babies, it's a disgrace."
The McCullough Foundation review released last October assembled 107 studies tying vaccination to autism, other neurodevelopmental disorders or brain injury, and described a clinical sequence running from multiple shots to fever, seizures, encephalitis, brain injury, regression and an autism diagnosis. Autism prevalence, that review argued, jumped on the order of 32,000 percent as the U.S. schedule swelled toward 72 doses.
Vaccines are not the only exposure officials spent years waving off. Internal Johnson & Johnson documents reported in September 2025 show the company's U.S. epidemiology director, Rachel Weinstein, writing in 2018 that "the weight of the evidence is starting to feel heavy to me" on prenatal Tylenol and neurodevelopmental disorders. A consumer-safety lead had already called the literature "a safety signal that needs to be evaluated" in 2008. Kenvue, the spun-off maker, still says there is no causal link.
Trump moved on the wider schedule in August. An executive order cut routine childhood recommendations to 11 core shots, ended the blanket push for hepatitis B, COVID-19 and influenza in healthy children, and told the Justice Department to challenge states that block religious or medical exemptions.
"In many cases, we were requiring 72 jabs for our beautiful, healthy, lovely, delicate little children," Trump said. Kennedy's assignment was to find the environmental exposure. "Genes don't cause epidemics."
The new survey analysis lands while the COVID product itself is still being sold into a thinner and thinner justification. Pediatric trials were never powered for autism, ADHD or special-education placement.
The Zenodo authors note that vaccine-derived spike has been reported in blood, monocytes, cerebral arteries and peripheral tissue months to years later, and that prenatal spike exposure produced autism-like behavior and neuroinflammation in male rats. That is their biological rationale. It is not a settled mechanism. It is also not nothing.
Around it sits a year of findings the agencies have not answered. FDA lot-release testing of Moderna's Spikevax recovered only 70 to 80 percent of a known endotoxin spike, with lipid nanoparticles capable of hiding most of an incorporated bacterial toxin from the assay.
A 35-year-old man who took three Pfizer shots, two from "E" batches, developed a heart tumor found 170 days after the first dose that doubled every 10 days and, once removed, contained fragments of Pfizer spike DNA.
Hulscher called that case "literally the smoking gun of turbo cancers."
A Nobel laureate warned Anthony Fauci in February 2021 that shot contents were reaching the placenta and the fetus and provoking an immune response in the amniotic fluid. Fauci told the public there were no red flags.
Myocarditis signals out of Israel were in hand by January 2021 and still described as mild months later.
On August 27 the FDA cleared Moderna's 2026-2027 formulas 81 days before the human study of those formulas was even scheduled to start.
And remember...
Congress is not done trying to close the exit. A Senate bill now in circulation would make it far harder for a parent or a state to decline a federal vaccine recommendation once the recommendation exists.
The survey paper is not a randomized trial, and its authors say so. What they also say is that no factor they could measure explains the autism gap, that the gap climbs with doses, and that it is largest in the children shot earliest.
Parents were told this product had been studied for the outcomes that wreck a childhood. It had not.
The federal file they were told not to worry about now shows the association in black and white. Stopping the shots in children is the minimum a government owes the families still being offered them.
Tyler Durden Tue, 10/06/2026 - 10:20